CLINICAL_TRIALS
withdrawal
· 2012-08-28
Clinical Trial Update: A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED) [Phase 1]
Summary
Phase 1 multiple-dose trial of MK-1006 was terminated, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: TERMINATED | Results posted: 2012-08-28